
Sign up to save your podcasts
Or
Jonathan Rosenberg joins Brian and Tom to discuss this important phase 3 trial and efficacy and toxicity signals.
4.9
5555 ratings
Jonathan Rosenberg joins Brian and Tom to discuss this important phase 3 trial and efficacy and toxicity signals.
135 Listeners
14 Listeners
321 Listeners
502 Listeners
692 Listeners
59 Listeners
2,423 Listeners
3,329 Listeners
8,027 Listeners
196 Listeners
519 Listeners
2 Listeners
30 Listeners
181 Listeners
2 Listeners